Talimogene laherparepvec and Multiple myeloma
Result of checking the interaction of drug Talimogene laherparepvec and disease Multiple myeloma for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Plasmacytoma, in proximity to the injection site, has been reported after administration of talimogene laherparepvec in a patient with smoldering multiple myeloma. It is recommended to consider the risks and benefits of treatment in patients with multiple myeloma or in whom plasmacytoma develops during treatment. Close monitoring is recommended.
Generic Name: talimogene laherparepvec
Brand Name: Imlygic
Synonyms: Talimogene Laherparepvec